NCT04630015View on ClinicalTrials.gov

Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth

CompletedOBSERVATIONAL
Enrollment

134

Participants

Timeline

Start Date

August 31, 2020

Primary Completion Date

May 1, 2023

Study Completion Date

May 1, 2023

Conditions
COVID-19 InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Interventions
OTHER

Survey Administration

Participants will complete study specific survey

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT04630015 - Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth | Biotech Hunter | Biotech Hunter